1. Home
  2. FSP vs MOLN Comparison

FSP vs MOLN Comparison

Compare FSP & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Street Properties Corp.

FSP

Franklin Street Properties Corp.

HOLD

Current Price

$0.68

Market Cap

72.4M

Sector

Real Estate

ML Signal

HOLD

Logo Molecular Partners AG

MOLN

Molecular Partners AG

HOLD

Current Price

$4.00

Market Cap

158.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSP
MOLN
Founded
1981
2004
Country
United States
Switzerland
Employees
28
N/A
Industry
Real Estate Investment Trusts
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
72.4M
158.9M
IPO Year
2001
2021

Fundamental Metrics

Financial Performance
Metric
FSP
MOLN
Price
$0.68
$4.00
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$8.38
AVG Volume (30 Days)
589.0K
3.4K
Earning Date
04-28-2026
05-14-2026
Dividend Yield
5.73%
N/A
EPS Growth
15.69
N/A
EPS
N/A
N/A
Revenue
$107,162,000.00
N/A
Revenue This Year
$17.91
N/A
Revenue Next Year
N/A
$318.52
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.56
$3.36
52 Week High
$1.88
$5.36

Technical Indicators

Market Signals
Indicator
FSP
MOLN
Relative Strength Index (RSI) 53.85 31.45
Support Level $0.56 $3.51
Resistance Level $0.89 $4.01
Average True Range (ATR) 0.06 0.22
MACD 0.02 -0.07
Stochastic Oscillator 92.71 10.78

Price Performance

Historical Comparison
FSP
MOLN

About FSP Franklin Street Properties Corp.

Franklin Street Properties Corp is a real estate investment trust. The company is focused on commercial real estate investments in office markets and currently operate in only one segment: real estate operations. The principal revenue sources for its real estate operations include rental income from real estate leasing, property dispositions and fee income from asset/property management and development. The company provides asset management, property management, property accounting, investor and/or development services to its portfolio and Sponsored REIT through the company's subsidiaries.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

Share on Social Networks: